Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2003
05/28/2003EP1314423A1 Medicinal compositions
05/28/2003EP1313885A2 Methods of using agents that modulate bone formation and inhibit adipogenesis
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313875A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
05/28/2003EP1313874A1 Pharmaceutical compositions comprising a modulator of adamts-1
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313844A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313839A1 Immune potentiating compositions
05/28/2003EP1313820A2 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313732A1 Oxindole derivatives
05/28/2003EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313714A1 Valsartan salts
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313509A2 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
05/28/2003EP1313508A2 Combination containing an antifolate and methylmalonic acid lowering agent
05/28/2003EP1313507A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
05/28/2003EP1313504A2 Methods and compositions for inhibiting angiogenesis
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1313488A1 Compositions and methods for improving cardiovascular function
05/28/2003EP1313485A2 Use of an aldosterone receptor antagonist to improve cognitive function
05/28/2003EP1313483A2 Methods for inducing apolipoprotein e secretion
05/28/2003EP1313480A2 Use of an arylaldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/28/2003EP1313479A1 Hair loss prevention
05/28/2003EP1313478A2 Method for treatment of migraine using pde5 inhibitors
05/28/2003EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP1313465A1 Composition and method for treatment of hypertriglyceridemia
05/28/2003EP1313462A1 Use of asiatic acid or asiaticoside for treatment of cancer
05/28/2003EP1313422A1 Non-hormonal vaginal contraceptive
05/28/2003EP1313415A2 Devices for intraocular drug delivery
05/28/2003EP1313377A2 Treatment of helicobacter with isothiocyanates
05/28/2003EP1232173B1 Fusidic acid derivatives
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor
05/28/2003EP1165108B1 Use of a serenoa repens extract for the production of a medicament to treat prostate cancer
05/28/2003EP1150988B1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
05/28/2003EP1150664B1 Novel use of orexin receptor antagonists
05/28/2003EP1146884A4 Novel polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and methods for making same
05/28/2003EP1140188B1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
05/28/2003EP1107749B1 Fumaric acid derivatives for the treatment of transplant rejection
05/28/2003EP1067916B1 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
05/28/2003EP1039904B1 Synergistic antimicrobial compositions
05/28/2003EP1032415B1 Composition for the treatment of allergic conditions with cysteine and serine proteinase inhibitors
05/28/2003EP1011682B1 Hormonal contraceptive
05/28/2003EP0971713B1 Use of cholinesterase inhibitors to treat disorders of attention
05/28/2003EP0939641B1 Topical products as prophylactic or curative agents for bacterial skin infections
05/28/2003EP0904097B1 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003EP0814789B1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
05/28/2003EP0786995B1 Use of 5-(tetradecyloxy)-2-furan carboxylic acid for treating alzheimer's disease or psychosis
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420788A Improved treatment of neovascularization
05/28/2003CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420785A Method of treating cancer with anti-neurotrophin agents
05/28/2003CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules
05/28/2003CN1420775A Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/28/2003CN1420774A Sustained release beadlets conty. stavudine
05/28/2003CN1420769A Method of treating osteoarthritis with inducible nitric oxide synthase inhibitors
05/28/2003CN1420768A Combination product comprising non-steroidal antiandrogen and EGFR tyrosine kinase inhibitor
05/28/2003CN1420767A Pharmaceutical formulation contg. tolterodine and its use
05/28/2003CN1420766A Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
05/28/2003CN1420765A Method for chemoprevention of prostate cancer
05/28/2003CN1420762A Devices for delivery of drugs having antiprogestinic properties
05/28/2003CN1420759A Slimming composition contg. substance inducing IL-6 production
05/28/2003CN1420755A Method and composition for treatment of scars
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420125A Trichina antigen gene Ts 87 and use thereof
05/28/2003CN1109749C Pressure-mediated intracellular delivery of molecules or microparticles
05/28/2003CN1109547C Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine deriv. and HMG-CoA reductase inhibitor
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569905 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
05/27/2003US6569902 Inhibiting initiation or development of cancer by administering an effective dose of a nitrone free radical trapping agent to a subject
05/27/2003US6569887 (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
05/27/2003US6569885 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569879 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma; benzisoxazole compounds; e.g. ((5,7-dipropyl-3-trifluoromethyl-1,2-benzisoxazol-6-yl)oxy)acetic acid, methyl ester
05/27/2003US6569864 1.75 mu M of acyclovir and 1 mu g/ml of fusaric acid; viricides
05/27/2003US6569853 Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
05/27/2003US6569850 Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tyrptophan and possibly a vitamin B12 compound
05/27/2003US6569830 Dosage form of lysostaphin and a beta-lactam antibiotic such as a penicillin, a cepalosporin and a carbapenem; synergistic combination
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease
05/27/2003US6569655 For use in therapeutics, diagnostics, and as research tools
05/27/2003US6569638 Method for screening compounds for the treatment of neoplasia
05/27/2003US6569483 Dietetic food composition and dietetic method using such composition
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1151